"Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV".

Adriana Cervo Giada SebastianiJovana MilicThomas KrahnSergio MazzolaSalvatore PettaAntonio CascioGiovanni GuaraldiGiovanni Mazzola

Published in: HIV medicine (2022)

Assessment of cardiovascular disease should be targeted in people living with HIV with NAFLD and/or significant liver fibrosis, even if they are normoweight and young.

Keyphrases

liver fibrosis
cardiovascular disease
antiretroviral therapy
hiv positive
hiv infected
human immunodeficiency virus
hiv testing
hepatitis c virus
hiv aids
cancer therapy
type diabetes
men who have sex with men
middle aged
cardiovascular risk factors
drug delivery